We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CASBF market cap is 490.88M. The company's latest EPS is CNY -11.1760 and P/E is -0.33.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
Total Revenue | 0 | 18.54M | 4.3B | 1.03B | 345.18M |
Operating Income | -204.21M | -440.32M | 1.8B | -1.45B | -2.04B |
Net Income | -156.77M | -396.64M | 1.91B | -909.43M | -1.48B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
Total Assets | 1.78B | 6.75B | 11.87B | 11.47B | 9.32B |
Total Liabilities | 313.98M | 677.22M | 3.33B | 4.22B | 4.03B |
Total Equity | 1.47B | 6.07B | 8.55B | 7.25B | 5.29B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
Operating | -170.19M | -469.39M | 2.01B | -1.89B | -916.25M |
Investing | -797.77M | -182.71M | -2.53B | -1.19B | -441.62M |
Financing | 1.09B | 4.92B | 1.56B | 854.6M | -7.58M |
Market Cap | 490.88M |
Price to Earnings Ratio | -0.33 |
Price to Sales Ratio | 1.42 |
Price to Cash Ratio | 0.24 |
Price to Book Ratio | 0.09 |
Dividend Yield | - |
Shares Outstanding | 132.67M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 1.05k |
52 Week Change | 20.13% |
52 Week High | 4.225 |
52 Week Low | 1.86 |
Spread (Intraday) | 0.39 (9.9%) |
Company Name | Cansino Biologics Inc (PK) |
Address |
401-420, 4th floor tianjin |
Website | https://www.cansinotech.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions